Table 1.

Patients Receiving CI C/T Outpatient Therapy

Patient	Infectious Diagnosis	Pathogen	Susceptible to C/T?	Antibiotic Allergies	Dose/Day (Grams)	Duration (Days)	Satisfaction Score (avg)
1a,b	cUTI	MDR Pseudomonas aeruginosa	Susceptible (25-mm zone diameter)	PCN	4.5	14	N/A
2a	Pneumonia	P aeruginosa	Not tested	None	4.5	17	N/A
3a	Pneumonia	P aeruginosa	Not tested	None	9	6	N/A
4	Discitis	P aeruginosa	Not tested	PCN	4.5	42	N/A
5a,b	cUTI	MDR P aeruginosa	Intermediate (Etest MIC = 8/4 mcg/mL)	Erythromycin	4.5	7	4
6a,b	Bacteremia	P aeruginosa Escherichia coli	Not tested	PCN, Sulfa	4.5	10	4.2
7a	Pneumonia	MDR P aeruginosa	Susceptible (Etest MIC 2/4 mcg/mL)	Doxycycline	4.5	14	5

Abbreviations: avg, average; CI, continuous infusion; C/T, ceftolozane/tazobactam; cUTI, complicated urinary tract infection; MDR, multidrug-resistant; MIC, minimum inhibitory concentration; N/A, not applicable; PCN, penicillin.

^aClinical cure (6 of 7 patients).

^bMicrobiological cure (3 of 3 patients).